The John Radcliffe Hospital is a large tertiary teaching hospital in Oxford, England. It forms part of the Oxford University Hospitals NHS Foundation Trust and is named after John Radcliffe, an 18th-century ...

During the past decade, John Radcliffe Hospital conducted 146 clinical trials. In the 10-year time frame, 146 clinical trials started and 50 clinical trials were completed, i.e. on average, 34.2% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 38 clinical trials were completed. i.e. 60.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Radcliffe Hospital" #1 sponsor was "Children's Cancer and Leukaemia Group" with 27 trials, followed by "University of Oxford" with 25 trials sponsored, "Oxford University Hospitals NHS Trust" with 21 trials sponsored, "Boston Scientific Corporation" with 14 trials sponsored and "Celgene" with 14 trials sponsored. Other sponsors include 181 different institutions and companies that sponsored additional 125 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Radcliffe Hospital" #1 collaborator was "Oxford University Hospitals NHS Trust" with 11 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 7 trials as a collaborator, "The Leeds Teaching Hospitals NHS Trust" with 5 trials as a collaborator, "University of Oxford" with 5 trials as a collaborator and "University of Edinburgh" with 4 trials as a collaborator. Other collaborators include 218 different institutions and companies that were collaborators in the rest 197 trials.

According to Clinical.Site data, the most researched conditions in "John Radcliffe Hospital" are "Brain and Central Nervous System Tumors" (14 trials), "Atrial Fibrillation" (11 trials), "Lymphoma" (11 trials), "Coronary Artery Disease" (8 trials) and "Neuroblastoma" (8 trials). Many other conditions were trialed in "John Radcliffe Hospital" in a lesser frequency.

Most popular intervention types in "John Radcliffe Hospital" are "Drug" (150 trials), "Device" (64 trials), "Procedure" (55 trials), "Biological" (31 trials) and "Other" (31 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (46 trials), "radiation therapy" (23 trials), "cyclophosphamide" (20 trials), "vincristine sulfate" (17 trials) and "carboplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "John Radcliffe Hospital" are 272 trials for "All" genders, 11 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "John Radcliffe Hospital". undefined are not yet recruiting, 36 are recruiting, 30 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 142 completed trials in John Radcliffe Hospital, undefined suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in John Radcliffe Hospital, 13 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 75 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 67 trials that are defined as “Not Applicable".